These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1248 related items for PubMed ID: 17009270

  • 1. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ.
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [Abstract] [Full Text] [Related]

  • 2. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP.
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [Abstract] [Full Text] [Related]

  • 3. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Proven A, Gabriel SE, Orces C, O'Fallon WM, Hunder GG.
    Arthritis Rheum; 2003 Oct 15; 49(5):703-8. PubMed ID: 14558057
    [Abstract] [Full Text] [Related]

  • 4. [Induction therapy with corticoid pulses for treatment of temporal arteritis].
    Krüger K.
    Z Rheumatol; 2007 Mar 15; 66(2):165-6. PubMed ID: 17294060
    [No Abstract] [Full Text] [Related]

  • 5. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.
    Chevalet P, Barrier JH, Pottier P, Magadur-Joly G, Pottier MA, Hamidou M, Planchon B, El Kouri D, Connan L, Dupond JL, De Wazieres B, Dien G, Duhamel E, Grosbois B, Jego P, Le Strat A, Capdeville J, Letellier P, Agron L.
    J Rheumatol; 2000 Jun 15; 27(6):1484-91. PubMed ID: 10852275
    [Abstract] [Full Text] [Related]

  • 6. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.
    Martínez-Taboada VM, Rodríguez-Valverde V, Carreño L, López-Longo J, Figueroa M, Belzunegui J, Mola EM, Bonilla G.
    Ann Rheum Dis; 2008 May 15; 67(5):625-30. PubMed ID: 18086726
    [Abstract] [Full Text] [Related]

  • 7. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H, Savino PJ, Gamble GG.
    Ophthalmology; 2005 Jun 15; 112(6):1098-103. PubMed ID: 15885780
    [Abstract] [Full Text] [Related]

  • 8. Role of oral cyclophosphamide in the treatment of giant cell arteritis.
    Quartuccio L, Maset M, De Maglio G, Pontarini E, Fabris M, Mansutti E, Mariuzzi L, Pizzolitto S, Beltrami CA, De Vita S.
    Rheumatology (Oxford); 2012 Sep 15; 51(9):1677-86. PubMed ID: 22627726
    [Abstract] [Full Text] [Related]

  • 9. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P, Astellas Corticosteroid Withdrawal Study Group.
    Ann Surg; 2008 Oct 15; 248(4):564-77. PubMed ID: 18936569
    [Abstract] [Full Text] [Related]

  • 10. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
    Miehlke S, Madisch A, Bethke B, Morgner A, Kuhlisch E, Henker C, Vogel G, Andersen M, Meier E, Baretton G, Stolte M.
    Gastroenterology; 2008 Nov 15; 135(5):1510-6. PubMed ID: 18926826
    [Abstract] [Full Text] [Related]

  • 11. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.
    Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA.
    N Engl J Med; 1999 Jun 24; 340(25):1941-7. PubMed ID: 10379017
    [Abstract] [Full Text] [Related]

  • 12. [Bolus of methylprednisolone and Horton's disease/rhizomelic pseudo-polyarthritis. Preliminary results of a pilot study of treating the bolus with low doses of corticoids].
    Juchet H, Arlet P, Ollier S, Montané de la Roque P, Le Tallec Y.
    Ann Med Interne (Paris); 1992 Jun 24; 143(2):85-8. PubMed ID: 1530225
    [Abstract] [Full Text] [Related]

  • 13. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids.
    Muley SA, Kelkar P, Parry GJ.
    Arch Neurol; 2008 Nov 24; 65(11):1460-4. PubMed ID: 19001164
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J, Zarković M, Stojanović M, Pepenezić Z, Randjelović G, Gligorović M, Trbojević B, Drezgić M, Nesović M.
    Srp Arh Celok Lek; 2000 Nov 24; 128(5-6):179-83. PubMed ID: 11089418
    [Abstract] [Full Text] [Related]

  • 15. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
    Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, Lutsky B.
    Respir Med; 2007 Mar 24; 101(3):628-37. PubMed ID: 16875813
    [Abstract] [Full Text] [Related]

  • 16. Recovery of visual function in patients with biopsy-proven giant cell arteritis.
    Foroozan R, Deramo VA, Buono LM, Jayamanne DG, Sergott RC, Danesh-Meyer H, Savino PJ.
    Ophthalmology; 2003 Mar 24; 110(3):539-42. PubMed ID: 12623817
    [Abstract] [Full Text] [Related]

  • 17. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
    Mahr AD, Jover JA, Spiera RF, Hernández-García C, Fernández-Gutiérrez B, Lavalley MP, Merkel PA.
    Arthritis Rheum; 2007 Aug 24; 56(8):2789-97. PubMed ID: 17665429
    [Abstract] [Full Text] [Related]

  • 18. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.
    Espígol-Frigolé G, Corbera-Bellalta M, Planas-Rigol E, Lozano E, Segarra M, García-Martínez A, Prieto-González S, Hernández-Rodríguez J, Grau JM, Rahman MU, Cid MC.
    Ann Rheum Dis; 2013 Sep 01; 72(9):1481-7. PubMed ID: 22993227
    [Abstract] [Full Text] [Related]

  • 19. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
    Liozon E, Boutros-Toni F, Ly K, Loustaud-Ratti V, Soria P, Vidal E.
    J Rheumatol; 2003 Jun 01; 30(6):1272-6. PubMed ID: 12784402
    [Abstract] [Full Text] [Related]

  • 20. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P, Chemlal K, Khalifa P, Wechsler B, De Gennes C, Belmatoug N, Cohen P, Ziza JM, Verdoncq B, Piette JC.
    J Rheumatol; 2001 Nov 01; 28(11):2474-9. PubMed ID: 11708421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.